0001209191-22-007860.txt : 20220208
0001209191-22-007860.hdr.sgml : 20220208
20220208192709
ACCESSION NUMBER: 0001209191-22-007860
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220208
FILED AS OF DATE: 20220208
DATE AS OF CHANGE: 20220208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Byrne Jason
CENTRAL INDEX KEY: 0001871145
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40631
FILM NUMBER: 22603382
MAIL ADDRESS:
STREET 1: CARIBOU BIOCIENCES, INC.
STREET 2: 2929 7TH STREET, SUITE 105
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Caribou Biosciences, Inc.
CENTRAL INDEX KEY: 0001619856
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 453728228
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 7TH STREET, SUITE 105
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 510-982-6030
MAIL ADDRESS:
STREET 1: 2929 7TH STREET, SUITE 105
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-08
0
0001619856
Caribou Biosciences, Inc.
CRBU
0001871145
O'Byrne Jason
C/O CARIBOU BIOSCIENCES, INC.
2929 7TH STREET, SUITE 105
BERKELEY
CA
94710
0
1
0
0
Chief Financial Officer
Common Stock
2022-02-08
4
M
0
24336
4.11
A
24336
D
Option to purchase Common Stock
4.11
2022-02-08
4
M
0
24336
0.00
D
2031-03-29
Common Stock
24336
412865
D
1/4th of the shares subject to this option vested on February 8, 2022 and an additional 1/48th of the aggregate number of shares subject to the option will vest on the corresponding day of each month thereafter until the option is fully vested on February 8, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates.
/s/ Barbara G. McClung, as attorney-in-fact
2022-02-08